Advertisement

Gain-of-function of ASXL1 truncating protein in the pathogenesis of myeloid malignancies

Hui Yang, Stefan Kurtenbach, Ying Guo, Ines Lohse, Michael A. Durante, Jianping Li, Zhaomin Li, Hassan AL-Ali, Lingxiao Li, Zizhen Chen, Matthew G. Field, Peng Zhang, Shi Chen, Shohei Yamamoto, Zhuo Li, Yuan Zhou, Stephen D. Nimer, J. William Harbour, Claes Wahlestedt, Mingjiang Xu and Feng-Chun Yang

Article Information

PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted June 8, 2017
  • Accepted October 28, 2017
  • Published online November 7, 2017.


Contributors 
  • Hui Yang, 1 Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, United States;
  • Stefan Kurtenbach, 2 Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, United States;
  • Ying Guo, 3 Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, United States;
  • Ines Lohse, 4 Center for Therapeutic Innovation and Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, United States;
  • Michael A. Durante, 2 Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, United States;
  • Jianping Li, 1 Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, United States;
  • Zhaomin Li, 1 Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, United States;
  • Hassan AL-Ali, 5 Department of Neurological Surgery, The Miami Project to Cure Paralysis, Peggy and Harold Katz Family Drug Discovery Center, University of Miami Miller School of Medicine, United States;
  • Lingxiao Li, 6 Department of Internal Medicine, University of Miami Miller School of Medicine, United States;
  • Zizhen Chen, 7 State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China;
  • Matthew G. Field, 2 Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, United States;
  • Peng Zhang, 3 Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, United States;
  • Shi Chen, 3 Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, United States;
  • Shohei Yamamoto, 3 Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, United States;
  • Zhuo Li, 3 Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, United States;
  • Yuan Zhou, 8 Center for Stem Cell Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
  • Stephen D. Nimer, 6 Department of Internal Medicine, University of Miami Miller School of Medicine, United States;
  • J. William Harbour, 1 Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, United States;
  • Claes Wahlestedt, 4 Center for Therapeutic Innovation and Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, United States;
  • Mingjiang Xu, 1 Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, United States;
  • Feng-Chun Yang, 1 Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, United States;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output